| 08/08/24 | 14:48:32 | 8 Aug 2024 | | Result of General Meeting and Total Voting Rights |
| 23/07/24 | 16:26:23 | 23 Jul 2024 | | Posting of Circular and General Meeting |
| 23/07/24 | 07:00:07 | 23 Jul 2024 | | Result of WRAP Retail Offer |
| 19/07/24 | 18:22:53 | 19 Jul 2024 | | Result of Placing and Subscription |
| 19/07/24 | 13:17:10 | 19 Jul 2024 | | WRAP Retail Offer to raise up to £1 million |
| 19/07/24 | 13:10:01 | 19 Jul 2024 | | Proposed Placing and Subscription |
| 28/06/24 | 14:35:15 | 28 Jun 2024 | | Result of AGM |
| 10/06/24 | 07:00:09 | 10 Jun 2024 | | Trading and Funding Update |
| 31/05/24 | 16:05:00 | 31 May 2024 | | Posting of 2023 Annual Report and Notice of AGM |
| 23/05/24 | 07:00:15 | 23 May 2024 | | Grant of Options and PDMR Dealing |
| 21/05/24 | 07:00:04 | 21 May 2024 | | Arecor to host company and KOL webinar today |
| 20/05/24 | 07:00:09 | 20 May 2024 | | Positive headline results for AT278 clinical trial |
| 16/05/24 | 07:00:09 | 16 May 2024 | | Final results for 2023 |
| 14/05/24 | 10:17:42 | 14 May 2024 | | Notice of Results |
| 09/05/24 | 07:00:09 | 9 May 2024 | | Arecor and Medtronic Diabetes collaboration |
| 03/05/24 | 16:44:19 | 3 May 2024 | | Publication of Full Year Financial Results delayed |
| 29/04/24 | 07:00:12 | 29 Apr 2024 | | Notice of results |
| 23/04/24 | 07:00:10 | 23 Apr 2024 | | BOARD CHANGE |
| 12/03/24 | 08:58:21 | 12 Mar 2024 | | Arecor and TRx Biosciences research collaboration |
| 12/03/24 | 07:00:10 | 12 Mar 2024 | | Arecor and TRx Biosciences research collaboration |
| 29/02/24 | 07:00:04 | 29 Feb 2024 | | Arecor announces launch of Ogluo® in Netherlands |
| 01/02/24 | 07:00:08 | 1 Feb 2024 | | Year End Trading Update |
| 23/01/24 | 16:58:46 | 23 Jan 2024 | | Arecor announces update on INBRX-101 |
| 18/01/24 | 07:00:04 | 18 Jan 2024 | | Arecor granted key European patent |
| 08/01/24 | 07:00:03 | 8 Jan 2024 | | Expansion of specialty hospital collaboration |
| 03/01/24 | 07:00:04 | 3 Jan 2024 | | Appointment of SVP for Tetris Pharma Ltd |
| 04/12/23 | 07:00:04 | 4 Dec 2023 | | Agreement with global medical products company |
| 29/11/23 | 07:00:11 | 29 Nov 2023 | | Arecor Continues Collaboration with Lilly |
| 17/11/23 | 07:00:07 | 17 Nov 2023 | | Product with Arestat technology launched in Europe |
| 02/11/23 | 07:00:11 | 2 Nov 2023 | | Inhibrx milestone triggers payment to Arecor |
| 01/11/23 | 15:31:11 | 1 Nov 2023 | | Exercise of rollover options & Total Voting Rights |
| 02/10/23 | 07:00:04 | 2 Oct 2023 | | Progress of Phase I clinical study of AT278 |
| 15/09/23 | 07:00:06 | 15 Sept 2023 | | Arecor on Investor Meet Company Platform |
| 14/09/23 | 07:00:04 | 14 Sept 2023 | | Interim Results for six months ended 30 June 2023 |
| 07/09/23 | 07:00:04 | 7 Sept 2023 | | Arecor: positive Hikma FDA pre-IND meeting |
| 04/09/23 | 07:00:05 | 4 Sept 2023 | | TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE |
| 17/08/23 | 07:00:02 | 17 Aug 2023 | | Collaboration With Top 10 Global Pharma |
| 10/08/23 | 07:00:06 | 10 Aug 2023 | | Notice of Interim Results |
| 20/07/23 | 07:00:06 | 20 Jul 2023 | | Arecor Business Update |
| 05/07/23 | 07:00:05 | 5 Jul 2023 | | Additional Agreement with Leading Biopharma |
| 27/06/23 | 07:00:04 | 27 Jun 2023 | | Arecor granted key patents in Europe and China |
| 26/06/23 | 07:00:04 | 26 Jun 2023 | | Arecor presents positive data for AT247 at ADA |
| 09/06/23 | 15:35:54 | 9 Jun 2023 | | Exercise of rollover options & Total Voting Rights |
| 09/06/23 | 12:43:31 | 9 Jun 2023 | | Result of AGM |
| 09/06/23 | 07:00:04 | 9 Jun 2023 | | AGM Statement |
| 24/05/23 | 07:00:14 | 24 May 2023 | | Director/PDMR Shareholding |
| 15/05/23 | 07:00:06 | 15 May 2023 | | TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY |
| 04/05/23 | 16:00:01 | 4 May 2023 | | ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM |
| 26/04/23 | 07:00:09 | 26 Apr 2023 | | Arecor Granted Key U.S Patent |
| 21/04/23 | 07:00:04 | 21 Apr 2023 | | Arecor on Investor Meet Company Platform |
